Exploring the Syndemic Role of MAFLD: From Metabolic Dysfunction to Infectious Risk

A scientific session titled “ Metabolic Dysfunction to Infectious Risk : The Syndemic Role of MAFLD ” was successfully conducted at the Transfusion Hall, Blood Centre, bringing together healthcare professionals to explore the growing impact of metabolic-associated fatty liver disease (MAFLD) on overall health outcomes.

The session highlighted MAFLD as a systemic metabolic condition that significantly influences disease risk and clinical outcomes, particularly in the context of Pakistan. Emphasis was placed on the importance of evidence-based nutrition and the need for a multidisciplinary approach to improve metabolic health and patient care.

The session featured insightful presentations by Dr. Muhammad Fahad, Ms. Maheen Saleem, Ms. Rameen Sarwar, and Dr. Sheikh Muhammad Saad, each addressing key aspects of MAFLD from their respective specialties. The session was moderated by Ms. Filza Khan and began with the recitation of the Holy Quran, followed by an introduction outlining the objectives of the session.

A total of 30 participants, including doctors, dietitians, and pharmacists, attended the session. Participants engaged in detailed discussions on MAFLD as a marker of systemic risk, its metabolic foundations, and the role of nutrition and pharmacotherapy in managing the condition.

The session also underscored the importance of recognizing nutrition as a core resilience strategy rather than merely supportive care. Experts highlighted the need for integrated clinical practices that combine medical treatment, dietary interventions, and pharmacological considerations to effectively address MAFLD and its associated risks.

The session concluded with certificate distribution. The program was accredited with Continuing Nutrition Education (CNE) from PNDS and Continuing Medical Education (CME) from DUHS, further enhancing its academic value.